Spondyloarthritis Biologics 'Game-Changing' for Juvenile Disease

(MedPage Today) -- Researchers continue to lay the groundwork for expanding treatment in juvenile spondyloarthritis (SpA), borrowing from advances in disease-modifying anti-rheumatic drugs (DMARDs) in adults. Earlier this year, the interleukin...